Minced cartilage implant may outperform standard microfracture for hip damage

NCT ID NCT07657871

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two surgical techniques for repairing cartilage damage in the hip caused by femoroacetabular impingement (FAI). One method, microfracture, creates tiny bone fractures to stimulate new cartilage growth. The other, minced cartilage implantation, uses the patient's own cartilage tissue, ground up and mixed with platelet-rich plasma, to patch the defect. Researchers will enroll 180 adults aged 18-50 and track their hip function and quality of life over time to see which approach works better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

minced cartilage implantation (autologous cartilage with platelet-rich plasma)

What this could lead to

If it works, this could offer a better surgical option for repairing hip cartilage damage, potentially delaying or preventing the need for hip replacement.

What could go wrong

This is a relatively early-stage comparison with 180 participants. The procedure is surgical and carries standard risks like infection or incomplete healing. It may not prove superior to microfracture.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMORO-ACETABULAR IMPINGEMENT (FAI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Femoracetabular Impingement Fractures, Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinique De La Sauvegarde

    Lyon, 69009, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • ICOSS

    Strasbourg, 67100, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••